Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.
RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.
3 Disclosed Funding Rounds $97,200,000
0 Participating Investments
Therapeutics, Health Care, Biotechnology, Information Technology
StrideBio, Inc. is a gene therapy company
Durham,
North Carolina,
United States,
North America
(US)
Organizations in Durham in Therapeutics,
Organizations in Durham in Health Care,
Organizations in Durham in Biotechnology,
Organizations in Durham in Information Technology,
Organizations in North Carolina in Therapeutics,
Organizations in North Carolina in Health Care,
Organizations in North Carolina in Biotechnology,
Organizations in North Carolina in Information Technology,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in United States in Information Technology,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology,
Organizations in North America in Information Technology
Investors in Durham in Therapeutics,
Investors in Durham in Health Care,
Investors in Durham in Biotechnology,
Investors in Durham in Information Technology,
Investors in North Carolina in Therapeutics,
Investors in North Carolina in Health Care,
Investors in North Carolina in Biotechnology,
Investors in North Carolina in Information Technology,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in United States in Information Technology,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Biotechnology,
Investors in North America in Information Technology
Southern US (0 Investors) (0 Startups), Research Triangle (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups)
Founded date 01, 2015
Founders
Mavis Agbandje,
Aravind Asokan,
Patrick Ritschel
Operating Status Active
Funding Stage Early Stage Venture
Last Funding Type Series B
Company Type For Profit
Contact
Hunter Lookup
LinkedIN
Wikipedia
StrideBio, LLC is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies and therapeutics for rare diseases. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies and improving gene transfer efficiency in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for a wide range of diseases, including rare genetic diseases. StrideBio is headquartered in Durham, NC.
| Date | Round | Raised | Lead |
|---|---|---|---|
| March, 16, 2021 | Series B | $81,500,000 |
Novo Holdings,
Northpond Ventures
|
| June, 13, 2018 | Series A | $15,700,000 |
Hatteras Venture Partners
|
| June, 01, 2017 | Seed | Undisclosed |
Hatteras Venture Partners
|
StrideBio Investors (16)
| Investor | Lead? | Round | Participating Raise | Date | Partners | ||
|---|---|---|---|---|---|---|---|
|
|
UCB Ventures | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
CaaS Capital Management | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Octagon Capital Advisors | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
UF Innovate Ventures | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Takeda Ventures | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Sarepta Therapeutics | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
Pontifax | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Novo Holdings | Yes | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Northpond Ventures | Yes | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Hatteras Venture Partners | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Alexandria Venture Investments | No | Series B | $81,500,000 | March, 16, 2021 | ------- |
|
|
|
Hatteras Venture Partners | Yes | Series A | $15,700,000 | June, 13, 2018 | ------- |
|
|
|
Takeda Ventures | No | Series A | $15,700,000 | June, 13, 2018 | ------- |
|
|
|
UCB Pharma | No | Series A | $15,700,000 | June, 13, 2018 | ------- |
|
|
|
Alexandria Venture Investments | No | Series A | $15,700,000 | June, 13, 2018 | ------- |
|
|
|
Hatteras Venture Partners | Yes | Seed | Undisclosed | June, 01, 2017 | ------- |
StrideBio in the News
Betakit
Related Companies All
Latest fundings in these markets All
New related Companies All
Also in Organization All
Similar People in Market All
Recommended
Recent Searches All
Latest Viewed All
